Insulin Degludec intermediates treatment specifications

As patients with type 2 diabetes progress, patients with poor effects of oral hypoglycemic drugs often need to be combined with insulin therapy to achieve effective blood sugar control. 6 Insulin Degludec intermediates must be used in the combined treatment plan, such as the basic Insulin. At the timing of initial treatment of intermediates, pay attention to the dose of basal insulin therapy and the method of adjustment. So what is the treatment specification for Insulin Degludec intermediates? Next, let us take a look.

Here is that the content:

l Timing of initial treatment for Insulin Degludec intermediates

l Dose adjustment plan for Insulin Degludec intermediates

Timing of initial treatment for Insulin Degludec intermediates

Timing of initiation of Insulin Degludec intermediates: Patients who have used more than one oral hypoglycemic drug in standard treatment combined with lifestyle intervention for more than 3 months, and whose blood glucose control is still not up to standard (glycated hemoglobin greater than or equal to 7%), may consider initiating Insulin Degludec intermediates treatment.

Dose adjustment plan for Insulin Degludec intermediates

The dosage adjustment plan of Insulin Degludec intermediates: After the initial basic insulin treatment, the insulin dosage should be adjusted in time according to the patient's fasting blood glucose, and the risk of hypoglycemia should be prevented. Following the principle of individualized treatment, doctors can guide patients to adjust the dosage of Insulin Degludec intermediates. It is usually adjusted once every 3 days until the fasting blood glucose (FPG) reaches the target. The specific adjustment methods are as follows: When the fasting blood glucose value is less than 4.4 mmol/l, the basal insulin dose is reduced by 2 units; when the fasting blood glucose value is between 4.4-6.1 mmol/l, the basal insulin dose is not adjusted; when the fasting blood glucose value is between 4.4 and 6.1 mmol/l the value is 6. 2-7. When the amount of insulin is between 8 millimoles/liter, the basic insulin dose is increased by 2 units; when the fasting blood glucose value is 7.0. Between 9-10 millimoles/liter, the dose of Insulin Degludec intermediates adds 4 units; when fasting blood glucose is greater than 10 moles/liter, the basic insulin dose adds 6 units.

Chengdu Pukang has a professional R&D team with first-class technology, rich experience, and innovative ideas, which can meet the various needs of customers from custom synthesis to mass production. Parking has sufficient resources to provide process development, optimization and scale-up production The R & D will cooperate with the production to solve the problems encountered in the pilot scale-up process. We are more professional, more efficient to provide customers with high-quality products.

This article is related to the relevant content of Insulin Degludec intermediates treatment specifications, On the condition of that you are interested in biology stable solution Insulin Degludec intermediates, injection grade 99% Insulin Degludec intermediates for energy metabolism, lab long-acting solid Insulin Degludec intermediates, TCA cycle synthesis crystal Insulin Degludec intermediates, you can consult our website, our website It is www.pu-kang.com. I look forward to your coming and hope to cooperate with you.